Third-party lab testing: 4 independent Janoshik assays on file, covering 4 substances, most recent test 2025-08-26.
Peptide supplier identified through Janoshik analytical testing records.
Atlaspharmaceuticals1 is listed as active. Discovered via Janoshik third-party lab testing.
| Substance | Measured purity | Test date |
|---|---|---|
| A | not reported | 2025-08-26 |
| Unnamed Sample | not reported | 2025-07-03 |
| Sample B | not reported | 2025-03-25 |
| Sample A | not reported | 2025-03-25 |
None of these 4 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 4 |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
Atlaspharmaceuticals1 is listed as active and we hold 4 independent Janoshik assays on file. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 4 third-party Janoshik assays for Atlaspharmaceuticals1, covering 4 substances. The most recent is dated 2025-08-26.
Similar vendors: opengatelabs.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Atomik Labz Peptides Review, Atomix Research Peptides Review, aurapp.5188 Peptides Review.